JMD Conference & Exhibition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bai, X.
Right arrow Articles by Scheuermann, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bai, X.
Right arrow Articles by Scheuermann, R. H.
JMD 2000, Vol. 2, No. 4
Copyright © 2000 American Society for Investigative Pathology & Association for Molecular Pathology

Predictive Value of Quantitative PCR-Based Viral Burden Analysis for Eight Human Herpesviruses in Pediatric Solid Organ Transplant Patients

Xin Bai*, Beverly Barton Rogers*, Paul C. Harkins{dagger}, John Sommerauer{dagger}, Robert Squires{dagger}, Kathleen Rotondo{dagger}, Albert Quan{dagger}, D. Brian Dawson* and Richard H. Scheuermann*

From the Departments of Pathology * and Pediatrics, {dagger} University of Texas Southwestern Medical Center, Dallas, Texas

Human herpesviruses can cause significant morbidity and mortality in pediatric solid organ transplant recipients. It was hypothesized that viral burden quantification by polymerase chain reaction using an internal calibration standard could aid in distinguishing between viral disease and latency. Here we report the results of a 2-year prospective study of 27 pediatric solid organ (liver, kidney, or heart) transplant recipients in which multiple samples were analyzed for levels of all eight human herpesviruses by internal calibration standard-polymerase chain reaction. Herpes simplex viruses 1 and 2, varicella-zoster virus, and Kaposi’s sarcoma-associated herpesvirus were not detected in any of these samples. Human herpesvirus types 6 and 7 were detected in half of the patients, but were present at low levels, similar to those found in reference populations. Epstein-Barr virus (EBV) and cytomegalovirus (CMV) were detected in 89% and 56% of the patients, respectively. Viral burden analysis suggested distinct patient populations for CMV, with a natural cutoff of 10,000 viral targets/ml blood strongly associated with disease. In some cases, a dramatic increase in CMV levels preceded clinical evidence of disease by several weeks. EBV viral burden was relatively high in the only patient presenting with an EBV syndrome. However, two other patients without evidence of EBV disease had single samples with high EBV burden. Rapid reduction in both EBV and CMV burden occurred with antiviral treatment. These data suggest that viral burden analysis using internal calibration standard-polymerase chain reaction for CMV, and possibly other herpesviruses, is an effective method for monitoring pediatric transplant patients for significant herpesvirus infection and response to therapy.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
J. S. Sheffield, J. B. Hill, L. M. Hollier, V. R. Laibl, S. W. Roberts, P. J. Sanchez, and G. D. Wendel Jr
Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
Obstet. Gynecol., July 1, 2006; 108(1): 141 - 147.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. B. Nye, A. R. Leman, M. E. Meyer, M. A. Menegus, and P. G. Rothberg
Sequence Diversity in the Glycoprotein B Gene Complicates Real-Time PCR Assays for Detection and Quantification of Cytomegalovirus
J. Clin. Microbiol., October 1, 2005; 43(10): 4968 - 4971.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
W. Habbal, F. Monem, and B. C. Gartner
Errors in Published Sequences of Human Cytomegalovirus Primers and Probes: Do We Need More Quality Control?
J. Clin. Microbiol., October 1, 2005; 43(10): 5408 - 5409.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. J. C. Stevens, S. A. W. M. Verkuijlen, B. Hariwiyanto, Harijadi, J. Fachiroh, D. K. Paramita, I. B. Tan, S. M. Haryana, and J. M. Middeldorp
Diagnostic Value of Measuring Epstein-Barr Virus (EBV) DNA Load and Carcinoma-Specific Viral mRNA in Relation to Anti-EBV Immunoglobulin A (IgA) and IgG Antibody Levels in Blood of Nasopharyngeal Carcinoma Patients from Indonesia
J. Clin. Microbiol., July 1, 2005; 43(7): 3066 - 3073.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
V. Leb, M. Stocher, E. Valentine-Thon, G. Holzl, H. Kessler, H. Stekel, and J. Berg
Fully Automated, Internally Controlled Quantification of Hepatitis B Virus DNA by Real-Time PCR by Use of the MagNA Pure LC and LightCycler Instruments
J. Clin. Microbiol., February 1, 2004; 42(2): 585 - 590.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
J. Jebbink, X. Bai, B. B. Rogers, D. B. Dawson, R. H. Scheuermann, and R. Domiati-Saad
Development of Real-Time PCR Assays for the Quantitative Detection of Epstein-Barr Virus and Cytomegalovirus, Comparison of TaqMan Probes, and Molecular Beacons
J. Mol. Diagn., February 1, 2003; 5(1): 15 - 20.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. Stocher and J. Berg
Normalized Quantification of Human Cytomegalovirus DNA by Competitive Real-Time PCR on the LightCycler Instrument
J. Clin. Microbiol., December 1, 2002; 40(12): 4547 - 4553.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology and the Association for Molecular Pathology.